Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update | SAMHSA

SAMHSA

Gives an overview of data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder. Discusses the implications of utilizing medication-assisted treatment a a recovery support.